Medtech Start-Ups: Protaryx Med., ivWatch, Resistell, MastOR, & more

Posted by Life Science Intelligence on Aug 12, 2020 11:07:41 AM

LSI's Medtech Start-Up Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.  

Protaryx Medical raises $5.1M in recent Series A

The company is developing a novel device that optimizes transseptal access to the left atrium during structural heart and catheter ablation procedures. To-date, the company has raised $8.3M. Key strategics in the structural heart devices market include Abbott, Edwards Lifesciences, and Medtronic.

Start a Free Trial to Medtech Start-Up Tracker Today

Read More

Topics: Strategics, Medtech, Medtech Venture Capital

Medtech Start-Ups: Quantib, Circadia Health, Tatch, BioSense, & more

Posted by Life Science Intelligence on Aug 11, 2020 10:40:42 AM

LSI's Medtech Start-Up Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.  

Quantib is developing artificial intelligence application for medical imaging analyses

The company currently commercializes two FDA-approved radiology imaging analysis platforms – Quantib ND and Quantib Brain. In June 2020, the company received a grant from the European Innovation Council $2.4M. Strategic competitors in this space include GE Healthcare, Philips, and Siemens

Start a Free Trial to Medtech Start-Up Tracker Today

Read More

Topics: Startup, Medtech, Medtech Venture Capital

Medtech Startups Competing with Elekta, Accuray, Abbott, Dexcom

Posted by Life Science Intelligence on Jun 9, 2020 9:49:53 AM

LSI's Medtech Start-Up Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.  

Read More

Topics: Startup, Strategics, Medtech, Medtech Venture Capital

Medtech Startups Competing with Medtronic, J&J, Boston Scientific

Posted by Life Science Intelligence on Jun 8, 2020 5:46:35 PM

VenoStent is developing a novel memory polymer for intravascular devices
The company is seeking to improve venous access in hemodialysis patients with its novel shape memory polymer technology. To-date the company has raised $1.3M. Key strategics in this market include: BD, Merit Medical, and W.L Gore.

Read More

Topics: Startup, Strategics, Medtech, Medtech Venture Capital

COVID-19 Impacts Procedure Volumes and Medical Devices Markets

Posted by Life Science Intelligence on Apr 8, 2020 6:38:43 PM

Medical Devices & Diagnostics (MD&D) companies know they are being impacted by the current pandemic and are seeking independent research to quantify how much their markets will decline or increase, how long the recovery will take, and what factors will determine that recovery.

Read More

Topics: Startup, Strategics, Medtech, Medtech Venture Capital, Surgical Procedure Volumes, COVID-19, Coronavirus

Impact of 2020 Crisis on Global Medical Devices & Diagnostics Market: New Forecasts from HRI & LSI

Posted by Life Science Intelligence on Mar 25, 2020 1:08:40 PM

In the latest report available in LSI's Medtech Pro Platform, Impact of 2020 Crisis on Global Medical Devices & Diagnostics Market, new forecasts and analysis based on the impact of COVID-19 are provided. More specifically, the report details the impact of the crisis annually for 2020 through 2025 on:

Read More

Topics: Insider, Startup, Strategics, Medtech, Medtech Venture Capital, Surgical Procedure Volumes

2020's Hottest Medtech Startups Raising $2.5B Drawing Attention

Posted by Life Science Intelligence on Jan 25, 2020 4:43:39 PM

In February 2020, over 100 medtech startups will gather at the Emerging Medtech Summit to present their investment and strategic partnering needs to an audience of venture capitalists, angel investors, family offices, PE firms and strategic buyers.

Read More

Topics: Startup, Strategics, Medtech, Medtech Venture Capital

Global Opportunities in the Catheter-based Electrophysiology Products Market

Posted by Life Science Intelligence on Jan 17, 2020 7:11:22 PM

The presence of an arrhythmia is confirmed when the heart beats at an irregular rate. Persistent arrhythmia necessitates clinical evaluation and may require some form of intervention to prevent the irregularity from becoming life-threatening. When left untreated, serious forms of arrhythmia can lead to serious complications, such as stroke and heart failure. Recurring arrhythmia can be managed with a number of therapeutic options, including pharmaceuticals, implantable devices (e.g. pacemakers), and ablative procedures.

Read More

Topics: Insider, Startup, Strategics, Medtech, Medtech Venture Capital, Surgical Procedure Volumes

Global Opportunities in Cerebral Embolization Markets

Posted by Life Science Intelligence on Jan 7, 2020 7:04:12 PM

Stroke is the second largest cause of death globally, claiming an estimated 5.5 million lives annually. The burden of stroke is expected to worsen in the future as a result of demographic and lifestyle changes in developed and developing countries. During the acute stage there are several pharmaceuticals and surgical procedures available to assist healthcare providers manage stroke patients. This market research report provides forecasts and analysis of the embolization products used in the management and treatment of stroke. In addition to market forecasts, this report provides insights into the leading competitors in the cerebral embolization products market.

Read More

Topics: Insider, Startup, Strategics, Medtech, Medtech Venture Capital, Surgical Procedure Volumes

Neurostimulation Technologies Targeting Neurological Conditions - Global Opportunities

Posted by Life Science Intelligence on Dec 29, 2019 8:26:09 AM

Neurostimulation devices are utilized to restore function and re-normalize the circuiting of the nervous system in neurological conditions such as drug-refractory epilepsy, major depressive disorder, post-stroke extremity dysfunction, as well as Alzheimer’s and Parkinson’s disease. Globally, neurological conditions affect hundreds of millions of people.

Read More

Topics: Startup, Strategics, Medtech, Medtech Venture Capital